+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Antiemetic Drugs Market by Indication, Drug Class, Route Of Administration, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5924704
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Antiemetic drug therapies are fundamentally reshaping supportive care within modern healthcare systems. As diverse treatment protocols become increasingly integrated, the global antiemetic drugs market stands at a pivotal phase of innovation, propelled by evolving clinical needs and continuous regulatory momentum.

Market Snapshot: Antiemetic Drugs Market Growth & Outlook

The Antiemetic Drugs Market has recorded steady expansion, growing from USD 5.92 billion in 2024 to USD 6.44 billion in 2025. With a projected compound annual growth rate (CAGR) of 8.75%, the market is forecast to reach USD 9.80 billion by 2030. This trajectory is shaped by a continued demand for therapies that effectively address treatment-induced nausea and vomiting in healthcare settings worldwide.

Scope & Segmentation

This report provides an in-depth analysis of the antiemetic drugs market, breaking down the sector by clinical purpose, formulation trends, and regional market dynamics. Key areas of segmentation include:

  • Indications: Chemotherapy-induced nausea and vomiting, post-operative nausea and vomiting, radiation-induced nausea and vomiting.
  • Drug Classes: Corticosteroids, dopamine antagonists, neurokinin 1 receptor antagonists, serotonin 5-HT3 receptor antagonists.
  • Routes of Administration: Intravenous formulations and oral formulations.
  • End Users: Hospitals, clinics, home care settings.
  • Distribution Channels: Hospital pharmacy, online pharmacy, retail pharmacy.
  • Geographic Coverage: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (featuring key countries such as United Kingdom, Germany, France, Russia, and others), Asia-Pacific (with focus markets including China, India, Japan, Australia, and Southeast Asian economies).
  • Leading Companies Profiled: Merck & Co., Inc., Helsinn Healthcare SA, Hoffmann-La Roche AG, GlaxoSmithKline plc, Novartis AG, Teva Pharmaceutical Industries Ltd., Pfizer Inc., Dr. Reddy’s Laboratories Ltd., Mylan N.V., Sun Pharmaceutical Industries Ltd.

Key Takeaways for Senior Decision-Makers

  • Personalized and targeted antiemetic regimens are gaining traction, with growing emphasis from clinical associations on real-world data integration and updated guidelines.
  • Breakthrough neurokinin 1 and next-generation serotonin 5-HT3 receptor antagonists are influencing a shift away from traditional monotherapies, supporting tailored patient risk management.
  • Innovations such as oral dispersible films, long-acting injectables, and digital health solutions are improving outpatient management and patient adherence.
  • Heterogeneous regulatory environments and healthcare infrastructure maturity are determining adoption rates and influencing market access strategies across regions.
  • Strategic collaborations, licensing agreements, and technology transfers between multinational pharmaceutical companies and regional manufacturers are accelerating time-to-market for innovative therapies.
  • Distribution channels are diversifying, with digital transformation enabling enhanced pharmacy networks and streamlined supply chains for improved patient access.

Assessing Tariff Impact in 2025

Recent U.S. tariffs on pharmaceutical imports have prompted manufacturers to pursue alternative procurement strategies and establish new domestic and nearshore supply agreements. As a result, supply chains are being reinforced for resilience, supported by regulatory efforts to expedite import approvals for essential supportive medications. Emerging shifts in pricing and distribution models are reinforcing the need for long-term supplier partnerships and robust cost management.

Methodology & Data Sources

This analysis is grounded in a hybrid research model, combining primary interviews with senior clinicians, regulatory experts, and supply chain specialists with secondary reviews of peer-reviewed literature, trial registries, and industry disclosures. Data triangulation and cross-functional validation were performed to ensure analytical accuracy and actionable insights.

Why This Report Matters

  • Supports evidence-based investment and commercial planning decisions for portfolio leaders and clinical strategists.
  • Enables market entrants and incumbents to align operational, regulatory, and partnership priorities by offering a granular view of emerging trends and disruptive technologies.
  • Facilitates targeted product positioning for innovative antiemetic therapies by mapping competitive advantage across clinical indication, delivery route, and regional channel.

Conclusion

The antiemetic drugs market is evolving through innovation, regulatory adaptation, and collaborative growth models. This report equips business leaders with actionable guidance to navigate risks, capitalize on transformational opportunities, and ensure resilient market positioning.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Expanding market for oral dissolvable ondansetron formulations tailored to pediatric and geriatric patients
5.2. Increasing integration of pharmacogenomics data to personalize antiemetic therapy in oncology patients
5.3. Surge in research on neurokinin-1 receptor antagonists addressing breakthrough chemotherapy-induced nausea
5.4. Strategic partnerships between biotech firms and generics manufacturers to co-develop cost effective antiemetic solutions
5.5. Rapid emergence of digital adherence tools and mobile apps enhancing patient compliance with antiemetic regimens
5.6. Growing investment in peptide based antiemetic candidates targeting central vomiting pathways
5.7. Impact of COVID-19 supply chain disruptions on availability of injectable antiemetic drugs in emerging markets
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Antiemetic Drugs Market, by Indication
8.1. Introduction
8.2. Chemotherapy-Induced Nausea And Vomiting
8.3. Post-Operative Nausea And Vomiting
8.4. Radiation-Induced Nausea And Vomiting
9. Antiemetic Drugs Market, by Drug Class
9.1. Introduction
9.2. Corticosteroids
9.3. Dopamine Antagonists
9.4. Neurokinin 1 Receptor Antagonists
9.5. Serotonin 5-HT3 Receptor Antagonists
10. Antiemetic Drugs Market, by Route Of Administration
10.1. Introduction
10.2. Intravenous
10.3. Oral
11. Antiemetic Drugs Market, by End User
11.1. Introduction
11.2. Clinics
11.3. Home Care Settings
11.4. Hospitals
12. Antiemetic Drugs Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Americas Antiemetic Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Antiemetic Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Antiemetic Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Merck & Co., Inc.
16.3.2. Helsinn Healthcare SA
16.3.3. Hoffmann-La Roche AG
16.3.4. GlaxoSmithKline plc
16.3.5. Novartis AG
16.3.6. Teva Pharmaceutical Industries Ltd.
16.3.7. Pfizer Inc.
16.3.8. Dr. Reddy’s Laboratories Ltd.
16.3.9. Mylan N.V.
16.3.10. Sun Pharmaceutical Industries Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ANTIEMETIC DRUGS MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ANTIEMETIC DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ANTIEMETIC DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. ANTIEMETIC DRUGS MARKET: RESEARCHAI
FIGURE 26. ANTIEMETIC DRUGS MARKET: RESEARCHSTATISTICS
FIGURE 27. ANTIEMETIC DRUGS MARKET: RESEARCHCONTACTS
FIGURE 28. ANTIEMETIC DRUGS MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. ANTIEMETIC DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY POST-OPERATIVE NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RADIATION-INDUCED NAUSEA AND VOMITING, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DOPAMINE ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY NEUROKININ 1 RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ORAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL ANTIEMETIC DRUGS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 50. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 51. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 52. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 61. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 62. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 63. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 64. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES ANTIEMETIC DRUGS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 73. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 74. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 75. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 76. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 77. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 78. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 79. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 80. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 81. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 82. CANADA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 83. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 84. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 85. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 86. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 87. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 88. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 89. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 90. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 91. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 92. MEXICO ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 93. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 94. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 95. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 96. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 103. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 104. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 105. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 106. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 113. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 114. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 115. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 125. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 126. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 127. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 128. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 135. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 136. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 137. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 138. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 139. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 140. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 141. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 142. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 143. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 144. GERMANY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 145. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 146. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 147. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 148. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 149. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 150. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 151. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 152. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 153. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 154. FRANCE ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 155. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 156. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 157. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 158. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 165. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 166. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 167. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 168. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 169. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 170. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 171. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 172. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 173. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 174. ITALY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 175. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 176. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 177. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 178. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 179. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 180. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 181. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 182. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 183. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 184. SPAIN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 185. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 186. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 187. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 188. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 195. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 196. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 198. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 206. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 207. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 208. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 215. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 216. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 217. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 218. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 219. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 220. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 221. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 222. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 223. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 224. DENMARK ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 225. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 226. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 227. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 228. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 235. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 236. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 237. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 238. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 239. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 240. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 241. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 242. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 243. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 244. QATAR ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 245. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 246. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 247. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 248. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 249. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 250. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 251. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 252. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 253. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 254. FINLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 255. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 256. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 257. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 258. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 265. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 266. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 267. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 268. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 275. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 276. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 277. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 278. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 279. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 280. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 281. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 282. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 283. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 284. EGYPT ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 285. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 286. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 287. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 288. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 289. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 290. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 291. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 292. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 293. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 294. TURKEY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 295. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 296. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 297. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 298. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 305. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 306. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 307. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 308. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 309. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 310. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 311. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 312. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 313. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 314. NORWAY ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 315. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 316. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 317. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 318. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 319. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 320. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 321. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 322. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 323. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 324. POLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 325. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 326. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 327. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 328. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 329. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 330. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 331. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 332. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 333. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 334. SWITZERLAND ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 335. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (USD MILLION)
TABLE 336. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2025-2030 (USD MILLION)
TABLE 337. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2024 (USD MILLION)
TABLE 338. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DRUG CLASS, 2025-2030 (USD MILLION)
TABLE 339. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2024 (USD MILLION)
TABLE 340. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2025-2030 (USD MILLION)
TABLE 341. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 342. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 343. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 344. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 345. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 346. ASIA-PACIFIC ANTIEMETIC DRUGS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 347. CHINA ANTIEMETIC DRUGS MARKET SIZE, BY INDICATION, 2018-2024 (US

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Antiemetic Drugs market report include:
  • Merck & Co., Inc.
  • Helsinn Healthcare SA
  • Hoffmann-La Roche AG
  • GlaxoSmithKline plc
  • Novartis AG
  • Teva Pharmaceutical Industries Ltd.
  • Pfizer Inc.
  • Dr. Reddy’s Laboratories Ltd.
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 6.44 Billion
Forecasted Market Value ( USD ) by 2030 $ 9.8 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Gastrointestinal Motility Drugs Market by Drug Type (Antiemetics, Antispasmodics, Laxatives), Mechanism Of Action (5-HT4 Agonists, Chloride Channel Activators, Dopamine Antagonists), Indication, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030 - Product Image

Gastrointestinal Motility Drugs Market by Drug Type (Antiemetics, Antispasmodics, Laxatives), Mechanism Of Action (5-HT4 Agonists, Chloride Channel Activators, Dopamine Antagonists), Indication, Route Of Administration, Distribution Channel, End User - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Antiemetic Drugs - Global Strategic Business Report - Product Image

Antiemetic Drugs - Global Strategic Business Report

  • Report
  • 179 Pages
  • Global
From
Antiemetics and Antinauseants Market Report 2025 - Product Image

Antiemetics and Antinauseants Market Report 2025

  • Report
  • 175 Pages
  • Global
From
Electronic Antiemetic Device Market by Application (Chemotherapy Induced Nausea And Vomiting, Motion Sickness, Postoperative Nausea And Vomiting), Type (Non Wearable Device, Wearable Device), End User, Distribution Channel - Global Forecast 2025-2030 - Product Image

Electronic Antiemetic Device Market by Application (Chemotherapy Induced Nausea And Vomiting, Motion Sickness, Postoperative Nausea And Vomiting), Type (Non Wearable Device, Wearable Device), End User, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 184 Pages
  • Global
From
Postoperative Nausea And Vomiting - Pipeline Insight, 2025 - Product Image

Postoperative Nausea And Vomiting - Pipeline Insight, 2025

  • Drug Pipelines
  • 60 Pages
  • Global
From

About the Antiemetic Market

The antiemetic market within the context of gastrointestinal drugs is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat nausea and vomiting. These drugs are used to treat a variety of conditions, including motion sickness, chemotherapy-induced nausea and vomiting, and postoperative nausea and vomiting. Antiemetics are also used to treat nausea and vomiting caused by certain medications, such as opioids. The antiemetic market is highly competitive, with a number of large pharmaceutical companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Merck & Co., Pfizer, Novartis, Sanofi, and Takeda Pharmaceuticals. Other companies, such as Sun Pharmaceuticals, Dr. Reddy's Laboratories, and Cipla, also offer antiemetic products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.